Cargando…
Neonatal Exposure to a Self-Peptide–Immunoglobulin Chimera Circumvents the Use of Adjuvant and Confers Resistance to Autoimmune Disease by a Novel Mechanism Involving Interleukin 4 Lymph Node Deviation and Interferon γ–mediated Splenic Anergy
Induction of neonatal T cell tolerance to soluble antigens requires the use of incomplete Freund's adjuvant (IFA). The side effects that could be associated with IFA and the ill-defined mechanism underlying neonatal tolerance are setbacks for this otherwise attractive strategy for prevention of...
Autores principales: | Min, Booki, Legge, Kevin L., Pack, Christopher, Zaghouani, Habib |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212393/ https://www.ncbi.nlm.nih.gov/pubmed/9841915 |
Ejemplares similares
-
Presentation of a T Cell Receptor Antagonist Peptide by Immunoglobulins Ablates Activation of T Cells by a Synthetic Peptide or Proteins Requiring Endocytic Processing
por: Legge, Kevin L., et al.
Publicado: (1997) -
Coupling of Peripheral Tolerance to Endogenous Interleukin 10 Promotes Effective Modulation of Myelin-Activated T Cells and Ameliorates Experimental Allergic Encephalomyelitis
por: Legge, Kevin L., et al.
Publicado: (2000) -
Role of Interleukin 12 and Costimulators in T Cell Anergy In Vivo
por: Parijs, Luk Van, et al.
Publicado: (1997) -
Role of interleukin 12 and costimulators in T cell anergy in vivo
por: Van Parijs, Luk, et al.
Publicado: (2009) -
Immunomodulators: interleukins, interferons, and IV immunoglobulin
por: Roelofs, Joris J., et al.
Publicado: (2008)